Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML.
Gosline SJC, Tognon C, Nestor M, Joshi S, Modak R, Damnernsawad A, Posso C, Moon J, Hansen JR, Hutchinson-Bunch C, Pino JC, Gritsenko MA, Weitz KK, Traer E, Tyner J, Druker B, Agarwal A, Piehowski P, McDermott JE, Rodland K.
Gosline SJC, et al. Among authors: traer e.
Clin Proteomics. 2022 Jul 27;19(1):30. doi: 10.1186/s12014-022-09367-9.
Clin Proteomics. 2022.
PMID: 35896960
Free PMC article.